公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
---|---|---|---|---|---|---|
1998 | Optimized conditions for growth and fermentation of Helicobacter pylori. | JIN-TOWN WANG ; Chang C.S.; JYH-CHIN YANG ; Lin J.T.; Wang T.H. | Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi | 1 | 0 | |
2004 | Phase II study of weekly oxaliplatin and 24-h infusion of high-dose 5-fluorouracil and folinic acid in the treatment of advanced gastric cancer | Chao Y.; KUN-HUEI YEH ; Chang C.J.; Chen L.T.; Chao T.Y.; Wu M.F.; Chang C.S.; Chang J.Y.; Chung C.Y.; Kao W.Y.; Hsieh R.K.; ANN-LII CHENG | British Journal of Cancer | 72 | 63 | |
2005 | Phase II study of weekly vinorelbine and 24-h infusion of high-dose 5-fluorouracil plus leucovorin as first-line treatment of advanced breast cancer | KUN-HUEI YEH ; YEN-SHEN LU ; CHIH-HUNG HSU ; Lin J.F.; Chao H.J.; Ta-Chen Huang ; Chung C.Y.; Chang C.S.; CHIH-HSIN YANG ; ANN-LII CHENG | British Journal of Cancer | 7 | 7 | |
1998 | Vacuolating toxin gene polymorphism among Helicobacter pylori clinical isolates and its association with m1, m2, or chimeric vacA middle types | JYH-CHIN YANG ; Kuo C.H.; Wang H.J.; Wang T.C.; Chang C.S.; Wang W.C. | Scandinavian Journal of Gastroenterology | 12 | 13 |